{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:50:02Z","timestamp":1787316602509,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cryopyrin-associated periodic syndrome (CAPS), a rare genetic autoimmune disease, is composed of familial cold autoinflammatory syndrome (FCAs), Muckle-Wells syndrome (MWS), and neonatal onset multisystem inflammatory disease (NOMID). MWS is caused by dominantly inherited or de novo gain-of-function mutations in the NOD-like receptor 3 (\n                      <jats:italic>NLRP3<\/jats:italic>\n                      ) gene. At present, there is no report about the variation of R262W in China.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      We reported a 3-year-old Chinese boy who had recurrent fever without obvious inducement, bilateral conjunctival congestion, and urticarial-like rash. Laboratory examination showed elevation in leukocyte count, neutrophil count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) and serum amyloid protein (SAA) levels. Whole exome sequencing identified a missense variation c.784-786delinsTGG (p.R262W) in the coding region of the\n                      <jats:italic>NLRP3<\/jats:italic>\n                      gene.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      A classical variant of the\n                      <jats:italic>NLRP3<\/jats:italic>\n                      gene in a patient with MWS was first reported in China.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-023-00795-x","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:11:28Z","timestamp":1676045488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature"],"prefix":"10.1186","volume":"21","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4985-1258","authenticated-orcid":false,"given":"Qiuye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"issue":"4","key":"795_CR1","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/art.22491","volume":"56","author":"I Aksentijevich","year":"2007","unstructured":"Aksentijevich I, Putnam CD, Remmers EF, Mueller JL, Le J, Kolodner RD, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56(4):1273\u201385. https:\/\/doi.org\/10.1002\/art.22491. (PMID: 17393462).","journal-title":"Arthritis Rheum"},{"issue":"11","key":"795_CR2","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","volume":"74","author":"R Levy","year":"2015","unstructured":"Levy R, G\u00e9rard L, Kuemmerle-Deschner J, Lachmann HJ, Kon\u00e9-Paut I, Cantarini L, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. 2015;74(11):2043\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204991. (PMID: 25038238).","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"795_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","volume":"81","author":"KM Hull","year":"2002","unstructured":"Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine. 2002;81(5):349\u201368. https:\/\/doi.org\/10.1097\/00005792-200209000-00002. (PMID: 12352631).","journal-title":"Medicine"},{"issue":"5","key":"795_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.autrev.2011.10.008","volume":"11","author":"D Rigante","year":"2012","unstructured":"Rigante D. The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev. 2012;11(5):348\u201356. https:\/\/doi.org\/10.1016\/j.autrev.2011.10.008. (PMID: 22024500).","journal-title":"Autoimmun Rev"},{"issue":"4","key":"795_CR5","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.berh.2020.101529","volume":"34","author":"S Georgin-Lavialle","year":"2020","unstructured":"Georgin-Lavialle S, Ducharme-Benard S, Sarrabay G, Savey L, Grateau G, Hentgen V. Systemic autoinflammatory diseases: Clinical state of the art. Best Pract Res Clin Rheumatol. 2020;34(4):101529.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"795_CR6","first-page":"235","volume":"31","author":"TJ Muckle","year":"1962","unstructured":"Muckle TJ, Wellsm,. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med. 1962;31:235\u201348 (PMID: 14476827).","journal-title":"Q J Med"},{"issue":"29","key":"795_CR7","first-page":"1628","volume":"150","author":"CW Appels","year":"2006","unstructured":"Appels CW, Kloppenburg M. Muckle-Wells syndrome: a rare periodic fever syndrome. Ned Tijdschr Geneeskd. 2006;150(29):1628\u201331 (PMID: 16901068).","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"3","key":"795_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/art.30149","volume":"63","author":"JB Kuemmerle-Deschner","year":"2011","unstructured":"Kuemmerle-Deschner JB, Tyrrell PN, Koetter I, Wittkowski H, Bialkowski A, Tzaribachev N, et al. Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome. Arthritis Rheum. 2011;63(3):840\u20139. https:\/\/doi.org\/10.1002\/art.30149. (PMID: 21360513).","journal-title":"Arthritis Rheum"},{"issue":"12","key":"795_CR9","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1002\/art.27696","volume":"62","author":"JB K\u00fcmmerle-Deschner","year":"2010","unstructured":"K\u00fcmmerle-Deschner JB, Tyrrell PN, Reess F, K\u00f6tter I, Lohse P, Girschick H, et al. Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum. 2010;62(12):3783\u201391. https:\/\/doi.org\/10.1002\/art.27696. (PMID: 20722029).","journal-title":"Arthritis Rheum"},{"issue":"3","key":"795_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","volume":"39","author":"LM Booshehri","year":"2019","unstructured":"Booshehri LM, Hoffman HM. CAPS and NLRP3. J Clin Immunol. 2019;39(3):277\u201386. https:\/\/doi.org\/10.1007\/s10875-019-00638-z. (PMID: 31077002).","journal-title":"J Clin Immunol"},{"issue":"10","key":"795_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10010128","volume":"1","author":"T Welzel","year":"2021","unstructured":"Welzel T, Kuemmerle-Deschner JB. Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today? J Clin Med. 2021;1(10):1. https:\/\/doi.org\/10.3390\/jcm10010128. (PMID: 33401496).","journal-title":"J Clin Med"},{"issue":"3","key":"795_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29(3):301\u20135. https:\/\/doi.org\/10.1038\/ng756. (PMID: 11687797).","journal-title":"Nat Genet"},{"issue":"3","key":"795_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s1074-7613(04)00046-9","volume":"20","author":"L Agostini","year":"2004","unstructured":"Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20(3):319\u201325. https:\/\/doi.org\/10.1016\/s1074-7613(04)00046-9. (PMID: 15030775).","journal-title":"Immunity"},{"issue":"2","key":"795_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417\u201326. https:\/\/doi.org\/10.1016\/s1097-2765(02)00599-3. (PMID: 12191486).","journal-title":"Mol Cell"},{"issue":"4","key":"795_CR15","doi-asserted-by":"publisher","first-page":"e0214999","DOI":"10.1371\/journal.pone.0214999","volume":"14","author":"TAT Tran","year":"2019","unstructured":"Tran TAT, Grievink HW, Lipinska K, Kluft C, Burggraaf J, Moerland M, et al. Whole blood assay as a model for in vitro evaluation of inflammasome activation and subsequent caspase-mediated interleukin-1 beta release. PLoS One. 2019;14(4):e0214999. https:\/\/doi.org\/10.1371\/journal.pone.0214999. (PMID: 30958862).","journal-title":"PLoS One"},{"issue":"6","key":"795_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","volume":"42","author":"IS Afonina","year":"2015","unstructured":"Afonina IS, M\u00fcller C, Martin SJ, Beyaert R. Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme. Immunity. 2015;42(6):991\u20131004. https:\/\/doi.org\/10.1016\/j.immuni.2015.06.003. (PMID: 26084020).","journal-title":"Immunity"},{"issue":"5","key":"795_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.berh.2008.08.009","volume":"22","author":"I Touitou","year":"2008","unstructured":"Touitou I, Kon\u00e9-Paut I. Autoinflammatory diseases. Best Pract Res Clin Rheumatol. 2008;22(5):811\u201329. https:\/\/doi.org\/10.1016\/j.berh.2008.08.009. (PMID: 19028365).","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"795_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrm1019","volume":"4","author":"J Tschopp","year":"2003","unstructured":"Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol. 2003;4(2):95\u2013104. https:\/\/doi.org\/10.1038\/nrm1019. (PMID: 12563287).","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"795_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1586\/1744666x.2015.1047765","volume":"11","author":"G Sarrabay","year":"2015","unstructured":"Sarrabay G, Grandemange S, Touitou I. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts. Expert Rev Clin Immunol. 2015;11(7):827\u201335. https:\/\/doi.org\/10.1586\/1744666x.2015.1047765. (PMID: 25979514).","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"795_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/ard.2010.138420","volume":"70","author":"L Cuisset","year":"2011","unstructured":"Cuisset L, Jeru I, Dumont B, Fabre A, Cochet E, Le Bozec J, et al. Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis. 2011;70(3):495\u20139. https:\/\/doi.org\/10.1136\/ard.2010.138420. (PMID: 21109514).","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"795_CR21","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1136\/annrheumdis-2011-201271","volume":"71","author":"Y Shinar","year":"2012","unstructured":"Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, et al. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis. 2012;71(10):1599\u2013605. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201271. (PMID: 22661645).","journal-title":"Ann Rheum Dis"},{"issue":"31","key":"795_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/nar\/gkg031","volume":"1","author":"C Sarrauste de Menthi\u00e8re","year":"2003","unstructured":"Sarrauste de Menthi\u00e8re C, Terri\u00e8re S, Pugn\u00e8re D, Ruiz M, Demaille J, Touitou I. INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res. 2003;1(31):282\u20135. https:\/\/doi.org\/10.1093\/nar\/gkg031. PMID: 12520003.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"795_CR23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10067-016-3523-3","volume":"36","author":"D Wu","year":"2017","unstructured":"Wu D, Shen M. Muckle-Wells syndrome in Chinese patients: a single center case series. Clin Rheumatol. 2017;36(4):965\u20139. https:\/\/doi.org\/10.1007\/s10067-016-3523-3. (PMID: 28028683).","journal-title":"Clin Rheumatol"},{"issue":"10","key":"795_CR24","first-page":"832","volume":"13","author":"Y Gong","year":"2014","unstructured":"Gong Y, Shen M. Clinical features of autoinflammatory diseases in 3 patients. Chin J Gen Pract. 2014;13(10):832\u20134.","journal-title":"Chin J Gen Pract"},{"issue":"5","key":"795_CR25","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4103\/0366-6999.200537","volume":"130","author":"J Hu","year":"2017","unstructured":"Hu J, Zhu Y, Zhang J-Z, Zhang R-G, Li H-M. A novel mutation in the pyrin domain of the NOD-like receptor family pyrin domain containing protein 3 in Muckle-Wells syndrome. Chin Med J. 2017;130(5):586\u201393.","journal-title":"Chin Med J"},{"issue":"12","key":"795_CR26","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s11427-017-9246-4","volume":"60","author":"C Li","year":"2017","unstructured":"Li C, Tan X, Zhang J, Li S, Mo W, Han T, et al. Gene mutations and clinical phenotypes in 15 Chinese children with cryopyrin-associated periodic syndrome (CAPS). Science China Life Sciences. 2017;60(12):1436\u201344.","journal-title":"Science China Life Sciences"},{"issue":"6","key":"795_CR27","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1086\/340786","volume":"70","author":"C Dod\u00e9","year":"2002","unstructured":"Dod\u00e9 C, Le D\u00fb N, Cuisset L, Letourneur F, Berthelot JM, Vaudour G, et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet. 2002;70(6):1498\u2013506. https:\/\/doi.org\/10.1086\/340786. (PMID: 11992256).","journal-title":"Am J Hum Genet"},{"key":"795_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/oarrr.S114447","volume":"9","author":"TA Tran","year":"2017","unstructured":"Tran TA. Muckle-Wells syndrome: clinical perspectives. Open Access Rheumatol. 2017;9:123\u20139. https:\/\/doi.org\/10.2147\/oarrr.S114447. (PMID: 28744167).","journal-title":"Open Access Rheumatol"},{"issue":"9","key":"795_CR29","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","volume":"74","author":"NM Ter Haar","year":"2015","unstructured":"Ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015;74(9):1636\u201344. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207546. (PMID: 26109736).","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"795_CR30","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jama.1990.03440110028006","volume":"263","author":"T Randall","year":"1990","unstructured":"Randall T. Thalidomide has 37-year history. JAMA. 1990;263(11):1474. https:\/\/doi.org\/10.1001\/jama.1990.03440110028006. (PMID: 2407870).","journal-title":"JAMA"},{"issue":"4","key":"795_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.molmed.2017.02.006","volume":"23","author":"D Millrine","year":"2017","unstructured":"Millrine D, Kishimoto T. A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders. Trends Mol Med. 2017;23(4):348\u201361. https:\/\/doi.org\/10.1016\/j.molmed.2017.02.006. (PMID: 28285807).","journal-title":"Trends Mol Med"},{"issue":"25","key":"795_CR32","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.2174\/0929867324666170601074646","volume":"24","author":"A Mercurio","year":"2017","unstructured":"Mercurio A, Adriani G, Catalano A, Carocci A, Rao L, Lentini G, et al. A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma. Curr Med Chem. 2017;24(25):2736\u201344. https:\/\/doi.org\/10.2174\/0929867324666170601074646. (PMID: 28571559).","journal-title":"Curr Med Chem"},{"issue":"34","key":"795_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/03009740410010236","volume":"3","author":"T Kallinich","year":"2005","unstructured":"Kallinich T, Hoffman HM, Roth J, Keitzer R. The clinical course of a child with CINCA\/NOMID syndrome improved during and after treatment with thalidomide. Scand J Rheumatol. 2005;3(34):246\u20139.https;doi.org\/10.1080\/03009740410010236. PMID: 16134734.","journal-title":"Scand J Rheumatol."},{"issue":"5","key":"795_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.intimp.2004.10.017","volume":"3","author":"MS Alexandre-Moreira","year":"2005","unstructured":"Alexandre-Moreira MS, Takiya CM, de Arruda LB, Pascarelli B, Gomez RN, Castro Faria Neto HC. LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model. Int Immunopharmacol. 2005;3(5):485\u201394.","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"795_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1046\/j.1365-2249.1999.01039.x","volume":"118","author":"SJ Oliver","year":"1999","unstructured":"Oliver SJ, Freeman SL, Corral LG, Ocampo CJ, Kaplan G. Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis. Clin Exp Immunol. 1999;118(2):315\u201321. https:\/\/doi.org\/10.1046\/j.1365-2249.1999.01039.x. (PMID: 10540197).","journal-title":"Clin Exp Immunol"},{"issue":"21","key":"795_CR36","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/nejm199911183412102","volume":"341","author":"S Singhal","year":"1999","unstructured":"Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999;341(21):1565\u201371. https:\/\/doi.org\/10.1056\/nejm199911183412102. (PMID: 10564685).","journal-title":"N Engl J Med"},{"issue":"3","key":"795_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1381612053382179","volume":"11","author":"K Yasui","year":"2005","unstructured":"Yasui K, Kobayashi N, Yamazaki T, Agematsu K. Thalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammation. Curr Pharm Des. 2005;11(3):395\u2013401. https:\/\/doi.org\/10.2174\/1381612053382179. (PMID: 15723633).","journal-title":"Curr Pharm Des"},{"issue":"2","key":"795_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0306-9877(97)90217-6","volume":"49","author":"MF McCarty","year":"1997","unstructured":"McCarty MF. Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis. Med Hypotheses. 1997;49(2):123\u201331. https:\/\/doi.org\/10.1016\/s0306-9877(97)90217-6. PMID: 9278924.","journal-title":"Med Hypotheses"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00795-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00795-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00795-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T06:16:12Z","timestamp":1676268972000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00795-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00795-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1875943\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Ethics Committee of Affiliatied Hospital of Qingdao University. All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards. A written informed consent was obtained from the patient\u2019s parents. Include a statement on ethics approval and consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential competing interests with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}